Immunotherapy , Innate immunity , Fibrolamellar carcinoma


Dr. Barry aims to determine how innate immune cells recognize cancer and regulate immune responses. He previously identified a novel set of immune cells that regulate immune responses that protect patients from melanoma. The number of these cells in a patient’s tumor can identify those patients who will benefit the most from immunotherapy. Dr. Barry and his team are learning more about the signals that control this set of innate immune cells in cancer. His goal is to generate novel therapies to increase cancer-killing immune responses and save lives from cancer.


Fred Hutch Public Health Sciences Division - Translational Research Program Assistant Professor
Fred Hutch Immunotherapy Integrated Research Center Member